Financially-Incentives to Improve Provider Compliance
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04634019 |
|
Recruitment Status :
Recruiting
First Posted : November 18, 2020
Last Update Posted : December 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Compliant Behavior Morbidity;Infant | Behavioral: Financially incentivized knowledge assessments | Not Applicable |
The main idea of the intervention is to conduct quarterly provider knowledge assessments at health facilities and to pay facilities a bonus if providers perform well on these tests. For the intervention, 12 clinical vignettes were created. These vignettes cover typical patient cases such as malaria, diarrhea and respiratory infections, and assess providers' ability to correctly diagnose and treat hypothetical questions. All medical staff members were informed hat every 3 month there would be a knowledge assessment based on these vignettes and that the results would determine the total bonus payment made to the facility.
Each quarter, facilities receive a supervision visit. During the supervision visits, one provider is randomly chosen for the knowledge assessments, and is tested on two randomly chosen vignette cases.
In order to create a quarterly performance score, the scores on the two vignettes are then averaged. Fifty percent of the overall facility quality score is determined by the general quality checklist that captures basic structural and process features of the facility. The remaining fifty percent are directly determined by the providers' performance on the knowledge assessments. If the overall quality score is below 50%, no quality payments are made. If the quality score is >=50%, facilities can receive a top-up payment of up to 25% of the quantity-based payments. The total bonus percentage is determined by multiplying the quality score (with ranges between 0 and 100%) with the maximum 25% bonus.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 500 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | This will be a two-arm parallel trial - control vs intervention. |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Financially-Incentivized Knowledge Assessments to Improve Provider Compliance With Treatment Guidelines: A Randomized Controlled Trial |
| Actual Study Start Date : | January 1, 2018 |
| Estimated Primary Completion Date : | June 30, 2022 |
| Estimated Study Completion Date : | December 31, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control arm
Providers in control facilities will not receive any additional training or knowledge assessments.
|
|
|
Experimental: Financial incentive arm
Providers in treatment facilities will be visited once a quarter for a knowledge assessment using vignettes. Facilities performing well in this assessment will receive a quarterly bonus payment, which will be distributed among providers.
|
Behavioral: Financially incentivized knowledge assessments
We will conduct quarterly provider knowledge assessments at selected health facilities and will pay facilities a financial bonus if providers perform well on these tests. For the intervention, 12 clinical vignettes were created. These vignettes cover typical patient cases such as malaria, diarrhea and respiratory infections, and assess providers' ability to correctly diagnose and treat hypothetical questions. All medical staff members will be informed hat every 3 month there will be a knowledge assessment based on these vignettes and that the results will determine the total bonus payment made to the facility.
Other Name: Provider knowledge assessments |
- Compliance with integrated management of childhood illness (IMCI) guidelines [ Time Frame: Endline (30 months after project start) ]Compliance will be measured through up to 8 direct observations of under-5 sick child visits at each facility collected over a four-day period. During each visit, trained observes will document how many of the 10 diagnostic steps specified in the WHO's Integrated Management of Child Illness (IMCI) are followed by the provider. Compliance will be defined as least 8 out of 10 diagnostic processes completed.
- Knowledge regarding IMCI guidelines [ Time Frame: Endline (30 months after project start) ]Knowledge of IMCI guidelines will be assessed through vignettes administered to providers at baseline and endline. A total of five vignettes will be given to providers, each describing a scenario involving a sick child under age 5. An overall knowledge score will be created to measure the extent to which the diagnosis and treatment chosen by providers matches those specified in the nationally used Integrated Management of Child Illness guidelines.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- all providers working at the 110 facilities selected for the study will be included in the study.
Exclusion Criteria:
- none.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04634019
| Contact: Gil Shapira, PhD | +1(202) 473-5038 | gshapira@worldbank.org | |
| Contact: Hadia Samaha, MS | hsamaha@worldbank.org |
| Congo, The Democratic Republic of the | |
| Congo Ministry of Public Health | Recruiting |
| Kinshasa, Congo, The Democratic Republic of the | |
| Contact: Claude Sese, MS | |
| Switzerland | |
| Swiss Tropical and Public Health Institute | Recruiting |
| Basel, BS, Switzerland, 4051 | |
| Contact: Günther Fink, PhD | |
| Principal Investigator: | Gil Shapira, PhD | World Bank |
| Responsible Party: | Swiss Tropical & Public Health Institute |
| ClinicalTrials.gov Identifier: | NCT04634019 |
| Other Study ID Numbers: |
IncentLearn |
| First Posted: | November 18, 2020 Key Record Dates |
| Last Update Posted: | December 3, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | The data collected as part of this project will be made available to researchers through the World Bank's data repository. |
| Supporting Materials: |
Study Protocol Analytic Code |
| Time Frame: | Upon completion of study |
| Access Criteria: | public access |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
financial incentives provider behavior vignettes |